Furthermore, we tested the responses for hypothetical scenarios returning Lynch syndrome pathogenic variant (MLH1) and hereditary breast and ovarian cancer syndrome (BRCA) results. This evidence concerns the gene MLH1 and Hereditary breast and ovarian cancer syndrome.